tiprankstipranks
Sellas Life Sciences’ zanubrutinib combination shows efficacy in DLBCL
PremiumThe FlySellas Life Sciences’ zanubrutinib combination shows efficacy in DLBCL
30d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
SELLAS Life Sciences Amends Severance for Key Executives
PremiumCompany AnnouncementsSELLAS Life Sciences Amends Severance for Key Executives
2M ago
Sellas Life Sciences announces key business objecives for 2025
Premium
The Fly
Sellas Life Sciences announces key business objecives for 2025
2M ago
SELLAS Life Sciences Advances Phase 3 AML Trial
Premium
Company Announcements
SELLAS Life Sciences Advances Phase 3 AML Trial
3M ago
Sellas Life Sciences reports Q3 EPS (10c), consensus  (13c)
PremiumThe FlySellas Life Sciences reports Q3 EPS (10c), consensus (13c)
4M ago
SLS Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SLS Upcoming Earnings Report: What to Expect?
4M ago
Sellas Life Sciences options imply 22.6% move in share price post-earnings
Premium
The Fly
Sellas Life Sciences options imply 22.6% move in share price post-earnings
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100